Q37840512 | 2015 UK National Guideline on the management of non-gonococcal urethritis. |
Q38922868 | 2016 European guideline on Mycoplasma genitalium infections |
Q37572093 | A cross-sectional study of Mycoplasma genitalium infection and correlates in women undergoing population-based screening or clinic-based testing for Chlamydia infection in London |
Q41603135 | A minimized motile machinery for Mycoplasma genitalium. |
Q47552294 | A silent epidemic: the prevalence, incidence and persistence of Mycoplasma genitalium among young, asymptomatic high-risk women in the United States |
Q36804189 | A triacylated lipoprotein from Mycoplasma genitalium activates NF-kappaB through Toll-like receptor 1 (TLR1) and TLR2. |
Q36553850 | Abnormal vaginal pH and Mycoplasma genitalium infection |
Q37191589 | Analysis identifying common and distinct sequences among Texas clinical strains of Mycoplasma genitalium |
Q38772340 | Antimicrobial-resistant sexually transmitted infections: gonorrhoea and Mycoplasma genitalium |
Q35934198 | Apparently-Different Clearance Rates from Cohort Studies of Mycoplasma genitalium Are Consistent after Accounting for Incidence of Infection, Recurrent Infection, and Study Design |
Q34315453 | Association between preterm birth and vaginal colonization by mycoplasmas in early pregnancy. |
Q36321280 | Association of Mycoplasma genitalium with infertility in North Indian women |
Q40215194 | Association of Recent Bacterial Vaginosis With Acquisition of Mycoplasma genitalium |
Q46260038 | Azithromycin treatment failure in Mycoplasma genitalium-positive patients with nongonococcal urethritis is associated with induced macrolide resistance |
Q38949023 | Background review for the 2016 European guideline on Mycoplasma genitalium infections |
Q89612603 | Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia |
Q54614037 | Cervicitis and genitourinary symptoms in women culture positive for Mycoplasma genitalium. |
Q37844311 | Cervicitis of unknown etiology |
Q37863918 | Chlamydia trachomatis infection in Sydney women |
Q37849099 | Chlamydia trachomatis, Mycoplasma genitalium and Ureaplasma urealyticum among students in northern Norway |
Q34298276 | Clinical characteristics associated with Mycoplasma genitalium among female sex workers in Nairobi, Kenya |
Q37119362 | Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease |
Q89456444 | Co-Infection of Human Papillomavirus with Mycoplasma Hominis/Ureaplasma Urealyticum Among Female Sex Workers in Medan, Indonesia |
Q35073368 | Comparison of transcription-mediated amplification and PCR assay results for various genital specimen types for detection of Mycoplasma genitalium |
Q36236663 | Comprehensive assessment of sociodemographic and behavioral risk factors for Mycoplasma genitalium infection in women |
Q36216576 | Correlates of cervical Mycoplasma genitalium and risk of preterm birth among Peruvian women |
Q47116580 | DETECTION OF MYCOPLASMA GENITALIUM IN FEMALE CERVICAL SAMPLES BY MULTITARGET REAL-TIME PCR. |
Q35531997 | Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis |
Q36241170 | Determination of infectious load of Mycoplasma genitalium in clinical samples of human vaginal cells |
Q54751509 | Development and Performance of a Microwell-Plate-Based Polymerase Chain Reaction Assay for Mycoplasma genitalium |
Q33884960 | Development of a quantitative real-time PCR assay for detection of Mycoplasma genitalium. |
Q35552784 | Diagnostic assessment of Mycoplasma genitalium in culture-positive women |
Q88995637 | Does the Sex Risk Quiz Predict Mycoplasma genitalium Infection in Urban Adolescents and Young Adult Women? |
Q36441494 | Epidemiology, pathogenesis and treatment of pelvic inflammatory disease. |
Q37611991 | Experimental Infection of Pig-Tailed Macaques (Macaca nemestrina) with Mycoplasma genitalium |
Q34591252 | Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease. |
Q36098434 | Functional analysis of the Mycoplasma genitalium MG312 protein reveals a specific requirement of the MG312 N-terminal domain for gliding motility |
Q33875386 | High Mycoplasma genitalium organism burden is associated with shedding of HIV-1 DNA from the cervix |
Q39109644 | High prevalence of Mycoplasma genitalium among female sex workers in Honduras: implications for the spread of HIV and other sexually transmitted infections |
Q34357166 | High prevalence of genital mycoplasmas among sexually active young adults with urethritis or cervicitis symptoms in La Crosse, Wisconsin |
Q35759848 | Homology modeling, comparative genomics and functional annotation of Mycoplasma genitalium hypothetical protein MG_237 |
Q37856734 | How men with non-chlamydial, non-gonococcal urethritis are managed in Australasia |
Q30820940 | Identification and characterization of immunogenic proteins of mycoplasma genitalium. |
Q37235788 | Identification of novel microbes associated with pelvic inflammatory disease and infertility |
Q33797838 | In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains |
Q33482038 | Intracellular Mycoplasma genitalium infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing |
Q34721011 | Intrastrain heterogeneity of the mgpB gene in Mycoplasma genitalium is extensive in vitro and in vivo and suggests that variation is generated via recombination with repetitive chromosomal sequences |
Q39033827 | MRI in pelvic inflammatory disease: a pictorial review. |
Q26796722 | Management of Mycoplasma genitalium infections - can we hit a moving target? |
Q27009515 | Microbial antigenic variation mediated by homologous DNA recombination |
Q40271087 | Multidrug-resistant Mycoplasma genitalium infections in Europe |
Q81353196 | Mycoplasma genitalium |
Q34190405 | Mycoplasma genitalium PCR: does freezing of specimens affect sensitivity? |
Q35854916 | Mycoplasma genitalium among adolescent women and their partners |
Q35056772 | Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease. |
Q56057553 | Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection |
Q33771940 | Mycoplasma genitalium among young, urban pregnant women |
Q37183482 | Mycoplasma genitalium and preterm delivery at an urban community health center |
Q34076727 | Mycoplasma genitalium as a contributor to the multiple etiologies of cervicitis in women attending sexually transmitted disease clinics |
Q36551175 | Mycoplasma genitalium as a sexually transmitted infection: implications for screening, testing, and treatment |
Q37253442 | Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women |
Q38609855 | Mycoplasma genitalium in Women: Current Knowledge and Research Priorities for This Recently Emerged Pathogen |
Q37186755 | Mycoplasma genitalium infection among HIV-positive women: prevalence, risk factors and association with vaginal shedding |
Q28083641 | Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis |
Q49711518 | Mycoplasma genitalium infection in Kenyan and US women |
Q36192824 | Mycoplasma genitalium infection in women attending a sexually transmitted infection clinic: diagnostic specimen type, coinfections, and predictors |
Q42355223 | Mycoplasma genitalium infections: current treatment options and resistance issues |
Q39293657 | Mycoplasma genitalium is associated with increased genital HIV type 1 RNA in Zimbabwean women |
Q40124458 | Mycoplasma genitalium on the Loose: Time to Sound the Alarm |
Q33613919 | Mycoplasma genitalium rapidly disseminates to the upper reproductive tracts and knees of female mice following vaginal inoculation |
Q43136741 | Mycoplasma genitalium symptoms, concordance and treatment in high-risk sexual dyads |
Q90111635 | Mycoplasma genitalium, a stealth female reproductive tract |
Q37099478 | Mycoplasma genitalium-encoded MG309 activates NF-kappaB via Toll-like receptors 2 and 6 to elicit proinflammatory cytokine secretion from human genital epithelial cells |
Q26748959 | Mycoplasma genitalium: An Emerging Sexually Transmitted Infection |
Q51506151 | Mycoplasma genitalium: Is It a Sexually Transmitted Pathogen? |
Q34403627 | Mycoplasma genitalium: a review |
Q36317299 | Mycoplasma genitalium: an efficient strategy to generate genetic variation from a minimal genome |
Q35659940 | Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease |
Q21131426 | Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women |
Q36728677 | Mycoplasma genitalium: an emerging sexually transmitted pathogen. |
Q35573004 | Mycoplasma genitalium: an organism commonly associated with cervicitis among west African sex workers |
Q35090137 | Mycoplasma genitalium: from Chrysalis to multicolored butterfly |
Q37136511 | Mycoplasma genitalium: prevalence and behavioural risk factors in the general population |
Q35532036 | Mycoplasma genitalium: prevalence, clinical significance, and transmission |
Q35542157 | Mycoplasma genitalium: should we treat and how? |
Q35608986 | Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases |
Q34097662 | Mycoplasmas and ureaplasmas as neonatal pathogens |
Q36059791 | Neighborhood drug markets: a risk environment for bacterial sexually transmitted infections among urban youth |
Q37036116 | Persistence, immune response, and antigenic variation of Mycoplasma genitalium in an experimentally infected pig-tailed macaque (Macaca nemestrina). |
Q37403799 | Prevalence and treatment outcome of cervicitis of unknown etiology |
Q35108563 | Prevalence of Mycoplasma genitalium and Mycoplasma hominis in urogenital tract of Brazilian women |
Q50026302 | Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis |
Q44090938 | Prevalence of Mycoplasma genitalium in early pregnancy and relationship between its presence and pregnancy outcome |
Q37856406 | Prevalence of Mycoplasma genitalium in health clinic attendees complaining of vaginal discharge in Bangladesh |
Q37182074 | Prevalence of rectal Trichomonas vaginalis and Mycoplasma genitalium in male patients at the San Francisco STD clinic, 2005-2006 |
Q34430738 | Proximal region of the gene encoding cytadherence-related protein permits molecular typing of Mycoplasma genitalium clinical strains by PCR-restriction fragment length polymorphism |
Q36162075 | RecA mediates MgpB and MgpC phase and antigenic variation in Mycoplasma genitalium, but plays a minor role in DNA repair |
Q34269050 | Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium |
Q35744202 | Relationship of Specific Bacteria in the Cervical and Vaginal Microbiotas With Cervicitis |
Q42689805 | Role of Mycoplasma and ureaplasma species in female lower genital tract infections |
Q34719702 | Sequence-based typing of Mycoplasma genitalium reveals sexual transmission |
Q34479272 | Sexually transmitted diseases treatment guidelines, 2015. |
Q33355815 | Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system |
Q47140897 | Should we screen for the sexually-transmitted infection Mycoplasma genitalium? Evidence synthesis using a transmission-dynamic model |
Q35572958 | Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection |
Q40181068 | Single-nucleotide polymorphisms in the rRNA operon and variable numbers of tandem repeats in the lipoprotein gene among Mycoplasma genitalium strains from clinical specimens |
Q35531416 | Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium than with Chlamydia trachomatis |
Q38560388 | The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-analysis |
Q43946787 | The epidemiology of HIV-1 infection in northern Tanzania: results from a community-based study |
Q88576444 | The vaginal microbiota and its association with human papillomavirus, Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium infections: a systematic review and meta-analysis |
Q34563401 | Transcriptional heat shock response in the smallest known self-replicating cell, Mycoplasma genitalium |
Q35052845 | Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with josamycin |
Q21133562 | Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic |
Q21296776 | Treatment of acute pelvic inflammatory disease |
Q48077493 | mgpB and mgpC sequence diversity in Mycoplasma genitalium is generated by segmental reciprocal recombination with repetitive chromosomal sequences |
Search more.